Published in Acta Diabetol Lat on June 13, 1981
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett (1994) 3.78
A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol (1998) 3.13
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol (1997) 2.06
Presence of a lattice structure in membrane fragments rich in nicotinic receptor protein from the electric organ of Torpedo marmorata. FEBS Lett (1973) 2.03
The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. J Virol (1999) 1.97
Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept. Eur J Biochem (1974) 1.90
Sequence-specific DNA binding of the progesterone receptor to the uteroglobin gene: effects of hormone, antihormone and receptor phosphorylation. EMBO J (1986) 1.74
Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab (1992) 1.62
Molecular properties of chloroplastic thioredoxin f and the photoregulation of the activity of fructose 1,6-bisphosphatase. Eur J Biochem (1981) 1.52
Association of DNA-bound progesterone receptors. Nature (1987) 1.51
Progress in the purification of the cholinergic receptor protein from Electrophorus electricus by affinity chromatography. FEBS Lett (1972) 1.47
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab (2000) 1.45
Studies on the cholinergic receptor protein of Electrophorus electricus. I. An assay in vitro for the cholinergic receptor site and solubilization of the receptor protein from electric tissue. Mol Pharmacol (1971) 1.43
Actinobacillus suis infection after a pig bite. Lancet (1996) 1.42
Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia (1977) 1.42
On the activation of fructose-1,6-bisphosphatase of spinach chloroplasts and the regulation of the Calvin cycle. Eur J Biochem (1981) 1.39
Immunological characterisation of the cholinergic receptor protein from Electrophorus electricus. FEBS Lett (1973) 1.38
Purification and properties of the cholinergic receptor protein from Electrophorus electricus electric tissue. Eur J Biochem (1974) 1.34
Studies on the cholinergic receptor protein from Electrophorus electricus. Effect of detergents on some hydrodynamic properties of the receptor protein in solution. FEBS Lett (1972) 1.32
Some physical properties of the cholinergic receptor protein from Electrophorus electricus revealed by a tritiated alpha-toxin from Naja nigricollis venom. Biochemistry (1972) 1.30
Regulatory behavior of monomeric enzymes. 2. A wheat-germ hexokinase as a mnemonical enzyme. Eur J Biochem (1974) 1.27
Receptors bound to antiprogestin from abortive complexes with hormone responsive elements. Nature (1988) 1.21
Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J (1991) 1.18
Kinetic study of the irreversible thermal denaturation of Bacillus licheniformis alpha-amylase. Biochem J (1989) 1.17
Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia (1972) 1.15
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol (1996) 1.11
Effects of pH and fructose 2,6-bisphosphate on oxidized and reduced spinach chloroplastic fructose-1,6-bisphosphatase. Eur J Biochem (1987) 1.10
Comparison between the affinities for reversible cholinergic ligands of a purified and membrane bound state of the acetylcholine-receptor protein from Electrophorus electricus. FEBS Lett (1973) 1.09
The rabbit uteroglobin gene. Structure and interaction with the progesterone receptor. J Biol Chem (1983) 1.08
[Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol (1998) 1.07
Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein. J Biol Chem (2000) 1.07
Isolation and purification of chloroplastic spinach (Spinacia oleracea) sedoheptulose-1,7-bisphosphatase. Biochem J (1987) 1.07
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Eur J Clin Pharmacol (1986) 1.05
[Extraction from electric tissue of gymnotus of a protein presenting several typical properties characteristic of the physiological receptor of acetylcholine]. C R Acad Sci Hebd Seances Acad Sci D (1970) 1.05
Enzyme memory. 1. A transient kinetic study of wheat-germ hexokinase LI. Eur J Biochem (1977) 1.05
Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol (1997) 1.05
Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci U S A (1996) 1.03
Compared effects of dithiotreitol on the interaction of an affinity-labeling reagent with acetylcholinesterase and the excitable membrane of the electroplax. Proc Natl Acad Sci U S A (1969) 1.03
Factors controlling gastric-glucagon release. J Clin Invest (1977) 1.02
Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J Virol (2001) 1.02
Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2. J Gen Virol (2001) 1.00
[Some physical properties of the acetylcholine protein receptor studied with a radioactive neurotoxin]. C R Acad Sci Hebd Seances Acad Sci D (1971) 1.00
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia (1983) 0.98
Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med (1970) 0.98
Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes. Eur J Pharmacol (1985) 0.98
Enzyme memory. 2. Kinetics and thermodynamics of the slow conformation changes of wheat-germ hexokinase LI. Eur J Biochem (1977) 0.96
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril (1986) 0.96
Affinity chromatography, on fructose-bisphosphatase-Sepharose, of two chloroplastic thioredoxins F. Purification and comparative molecular properties. Eur J Biochem (1984) 0.96
Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Mol Pharmacol (1983) 0.96
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab (1994) 0.95
Molecular modelling of the ORL1 receptor and its complex with nociceptin. Protein Eng (1998) 0.94
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action. Mol Cell Biol (1988) 0.94
Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J Clin Endocrinol Metab (1983) 0.93
The kinetics of the thermal deactivation of transglutaminase from guinea-pig liver. Eur J Biochem (1989) 0.92
Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes (1974) 0.92
[Separation of the receptor protein of acetylcholine and acetylcholinesterase]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.92
Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A. Mol Pharmacol (1999) 0.90
[3H]Tyr-D-Ser-Gly-Phe-Leu-Thr: a specific probe for the delta-opiate receptor subtype in brain membranes. Eur J Pharmacol (1982) 0.90
Kinetic studies of glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle. Eur J Biochem (1978) 0.90
Plasma glucagon levels in normal women during pregnancy. Diabetologia (1975) 0.90
Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci Lett (1997) 0.89
Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol (1975) 0.89
Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells. J Immunol (2001) 0.89
Structural, immunological and kinetic comparisons of NADP-dependent malate dehydrogenases from spinach (C3) and corn (C4) chloroplasts. Eur J Biochem (1986) 0.89
Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol (1989) 0.88
Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med (1976) 0.88
Glucagon and diabetes: a reappraisal. Diabetologia (1979) 0.88
Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism (1975) 0.88
Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp Physiol (1999) 0.87
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care (1984) 0.87
Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology (1978) 0.87
A low molecular weight inhibitor of steroid receptor activation. J Biol Chem (1977) 0.87
Biological properties of a transplantable islet-cell tumor of the golden hamster. 3. Electron microscopic studies. Diabetes (1968) 0.86
Effect of dog jejunum "glucagon-like immunoreactive material" on adipose tissue metabolism. Horm Metab Res (1969) 0.86
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab (1988) 0.86
Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism (1974) 0.86
Parenteral nutrition practices in hospital pharmacies in Switzerland, France, and Belgium. Nutrition (2004) 0.86
Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam Clin Pharmacol (1998) 0.86
Spinach (Spinacia oleracea) chloroplast sedoheptulose-1,7-bisphosphatase. Activation and deactivation, and immunological relationship to fructose-1,6-bisphosphatase. Biochem J (1988) 0.85
Dual specificity of casein kinase II from the yeast Yarrowia lipolytica. C R Acad Sci III (1995) 0.85
Purification and properties of factor XIII from human placenta. Int J Biochem (1992) 0.84
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) (1991) 0.84
The 'slow' pH-induced conformational transition of chloroplast fructose 1,6-bisphosphatase and the control of the Calvin cycle. Eur J Biochem (1984) 0.84
Enzyme memory. Effect of glucose 6-phosphate and temperature on the molecular transition of wheat-germ hexokinase LI. Eur J Biochem (1979) 0.84
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia (1983) 0.84